ACE2 and a Traditional Chinese Medicine Formula NRICM101 Could Alleviate the Inflammation and Pathogenic Process of Acute Lung Injury
CH Lin, YJ Chen, MW Lin, HJ Chang, XR Yang, CS Lin - Medicina, 2023 - mdpi.com
COVID-19 is a highly transmittable respiratory illness caused by SARS-CoV-2, and acute
lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS …
lung injury (ALI) is the major complication of COVID-19. The challenge in studying SARS …
Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice
Z Bi, W Hong, H Que, C He, W Ren, J Yang… - … and Targeted Therapy, 2021 - nature.com
The development of animal models for COVID-19 is essential for basic research and
drug/vaccine screening. Previously reported COVID-19 animal models need to be …
drug/vaccine screening. Previously reported COVID-19 animal models need to be …
A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
X Zhou, W Sun, Y Zhang, H Gu, R Wang, P Xie… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is
responsible for the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 uses the …
responsible for the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 uses the …
NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model
The coronavirus disease 2019 (COVID-19) pandemic continues to represent a challenge for
public health globally since transmission of different variants of the virus does not seem to …
public health globally since transmission of different variants of the virus does not seem to …
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF-and IFNγ-driven immunopathology
R Gawish, P Starkl, L Pimenov, A Hladik, K Lakovits… - Elife, 2022 - elifesciences.org
Despite tremendous progress in the understanding of COVID-19, mechanistic insight into
immunological, disease-driving factors remains limited. We generated maVie16, a mouse …
immunological, disease-driving factors remains limited. We generated maVie16, a mouse …
The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus
ABSTRACT A comprehensive analysis and characterization of a severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection model that mimics non-severe and severe …
syndrome coronavirus 2 (SARS-CoV-2) infection model that mimics non-severe and severe …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 ORF3a induces the expression of ACE2 in oral and pulmonary epithelial cells and the food supplement Vita …
A Aguilar-Lemarroy… - Experimental …, 2021 - … .spandidos-publications.com
Abstract The coronavirus disease 2019 (COVID‑19) pandemic has become a serious global
health problem and numerous studies are currently being conducted to improve …
health problem and numerous studies are currently being conducted to improve …
Generation and characterization of a humanized ACE2 mouse model to study long‐term impacts of SARS‐CoV‐2 infection
Although the COVID‐19 pandemic has officially ended, the persistent challenge of long‐
COVID or post‐acute COVID sequelae (PASC) continues to impact societies globally …
COVID or post‐acute COVID sequelae (PASC) continues to impact societies globally …
Ace2 and innate immunity in the regulation of SARS-CoV-2-induced acute lung injury: A review
L Qu, C Chen, T Yin, Q Fang, Z Hong, R Zhou… - International journal of …, 2021 - mdpi.com
Despite the protracted battle against coronavirus acute respiratory infection (COVID-19) and
the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function
ABSTRACT Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) emerged in
late 2019 and has spread worldwide resulting in the Coronavirus Disease 2019 (COVID-19) …
late 2019 and has spread worldwide resulting in the Coronavirus Disease 2019 (COVID-19) …